Skip to main content

Table 1 Clinical characteristics and microbiological data of patients

From: The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit

Patient Age Underlying disease Diagnosis at admission Type of infection Treatment (duration, days) Outcomed
Initial Definitive
Case#1 3 moa Pierre Robin Syndrome Septic shock (A. baumannii BSI) BSI RIF + COL (5) VAN + COL + MEM (12) Late relapse (UTI) Cured
Case#2 21 ys Spastic tetraparesis; dysphagia Respiratory failureb VAP & BSI RIF + COL (5) VAN + COL + MEM (15) Cured
Case#3 25 ys Spastic tetraparesis Respiratory failureb BSI VAN + COL + MEM (16) VAN + COL + MEMc Cured
Case#4 6 mo None ARDS VAP VAN + COL + MEM (19) VAN + COL + MEMc Cured
  1. COL colistin, VAN vancomycin, RIF rifampin, MEM meropenem, UTI urinary Tract Infection, BSI bloodstream infection, VAP Ventilator-Acquired Pneumonia, ARDS Acute Respiratory Distress Syndrome
  2. (a): Case-index; (b): caused by the underlying disease; (c): in cases #3-4 the initial therapy was the definitive one; (d): at least 3-months follow-up